You are on page 1of 11

Student Project 1

Pre-Travel Consultation
Ni Komang Surya Sanistiasih Budaya
1870121084
SGD 3
PRE TRAVEL CONSULTATION
o Effective pretravel consultations require
attention to the health background of the
traveler and incorporate the itinerary, trip
duration, travel purpose, and activities,
all of which determine health risks of the
trip in order to prepare travelers for the
health concerns that might arise during
their trips.
ANGOLA
o Southern African nation known for its capital Luanda,
Kissama Wildlife Reserve and Atlantic beaches.
o Total area 1,246,700 SQ KM.
o Estimated population 30,136,000.
o Angola has a tropical climate.
HEALTH RISK
VACCINE/MEDICINES- NON-VACCINE-
PREVENTABLE PREVENTABLE
DISEASES DISEASES

VECTORBORNE BLOODBORNE AIRBORNE & DROPLET


DISEASES DISEASES DISEASES
MALARIA
o Plasmodium falciparum malaria is one of the most important public health problems in
Angola, with more than three million cases confirmed between 2000–2013 and 7300
attributed deaths in 2013.
o Facing chloroquine drug resistance, Angola promptly adopqted artemisinin-based
combination therapy as the first-line to treat malaria.
o Chemoprophylaxis to prevent malaria is recommended, it involves taking a medicine
before, during, and after travel to an area with malaria.
MALARIA
o Several medications are available for malaria prophylaxis. When deciding which drug to
use, clinicians should consider the specific itinerary, length of trip, drug costs, previous
adverse reactions to antimalarials, drug allergies, and medical history.
NON-VACCINE-PREVENTABLE DISEASE:
ZIKA VIRUS

o Zika virus infections and suspected


microcephaly cases have been reported in
Angola since late 2016.
o Zika virus is an RNA virus of the Flavivirus
genus that is primarily transmitted by Aedes
spp mosquitoes.
ZIKA VIRUS
o ZIKV infection in humans is asymptomatic in about 80% of cases. When symptoms
occur, they are typically mild, self-limiting and similar to other arboviral infections.
o Vertical transmission of the virus leads to congenital Zika virus infection; sequelae
include microcephaly with brain anomalies and fetal loss.
o No vaccine or preventive drug is available. All travelers to areas with Zika virus
transmission should take steps to avoid mosquito bites to prevent the risk of Zika virus
and other vectorborne infections.
YELLOW FEVER (YF)
o In 2016 Angola faced Yellow Fever outbreak with 962 confirmed cases of yellow fever
across Angola and Congo.
o Three countries have reported Yellow Fever cases exported from Angola.
o Yellow fever (YF) virus is a single-stranded RNA virus that belongs to the genus
Flavivirus.
o YF is preventable by a relatively safe, effective vaccine.
YELLOW FEVER (YF)
o Because of the risk of serious adverse events after YF vaccination,
clinicians should only vaccinate people who are at risk of exposure to YF
virus or who require proof of vaccination to enter a country.
o Common adverse reactions are generally mild: including low-grade fever,
headache, and myalgia that last 5–10 days.
o Contraindications: infants younger than 6  months, hypersensitivity,
altered immune status.
REFERENCE
CDC Yellow Book. (2020). Oxford University Press
CDC. Student
(2020).
Angola, Project
Clinician View. 1 Available at
Pre-Travel Consultation
https://wwwnc.cdc.gov/travel/destinations/clinician/none/angola.
Accessed: 7/08/2020.
Ni Komang Surya Sanistiasih Budaya
SGD
Keystone, J. S., Kozarsky, P. E., 3/1870121084
Connor, B. A., Nothdurft, H. D., Mendelson, M., &
Leder, K. (2019). Travel Medicine (4th ed.). Elsevier Inc.

You might also like